Characterization of potential predictive biomarkers of response to nivolumab in CheckMate-141 in patients with squamous cell carcinoma of the head and neck (SCCHN).

This article has no abstract
Epistemonikos ID: 9314bedc8a2e41d59f00818348495d73a506749b
First added on: Feb 10, 2025